지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2018.9
- 수록면
- 39 - 45 (7page)
이용수
초록· 키워드
오류제보하기
Purpose: Food Allergen Immunotherapy (Oral) is a form of immunotherapy administered to patients who are allergic to foods such as egg, milk, and peanut. The food allergen is orally administered to the patient in an escalating dose for desensitization or tolerance development. The safety and effectiveness of the therapy were assessed using a systematic literature review and meta-analysis. Methods: For a literature search, 8 national databases and a number of international databases including Ovid-MEDLINE, Ovid-EMBASE, and Cochrane Library were used; and 13 articles (all from international databases) were selected. The target of Food Allergen Immunotherapy (Oral) included patients with food allergy, and the intervention was food allergen immunotherapy without limiting the food type. The safety and effectiveness of Food Allergen Immunotherapy (Oral) were assessed by reviewing all the articles reporting on the therapy. The control group received standard therapies including aversion therapy, no treatment, antihistamine treatment, and placebo. Safety was assessed through the incidence of complication and emergency medication. Effectiveness was assessed based on therapy success rate, symptomatic improvement, and quality of life. Results: Although Food Allergen Immunotherapy (Oral) was shown to have successful desensitization in patients with food allergy, the safety of the technique has not yet reached an acceptable level; the possible reason is due to the high rate of complication and frequency of emergency medication. Also, each study employed varying protocols while relying on a small number of participants and a short monitoring period. Conclusion: The results of assessment suggest that the level of evidence from current literature review is low and further research is necessitated for the verification of the safety and effectiveness of the therapy (Grade of Recommendation: A; Level of Technology: II-b).
목차
ABSTRACT
1. INTRODUCTION
2. MATERIALS AND METHODS
3. RESULTS
4. DISCUSSION
REFERENCES
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Development of RNA Structures for Cancer Immunotherapy
한국생물공학회 학술대회
2022 .09
-
Development of Dual Functional Oral Gene Delivery System for Immunotherapy and Diagnosis
한국고분자학회 학술대회 연구논문 초록집
2023 .10
-
Current Immunotherapy Approaches for Malignant Melanoma
BioChip Journal
2019 .01
-
Enhancing Cancer Immunotherapy using Biomaterials
한국생물공학회 학술대회
2019 .10
-
Development of SWNTs based biosensor for the assessment of peanut allergen
한국생물공학회 학술대회
2016 .10
-
Microfabricated Platforms for Cancer Immunotherapy
한국생물공학회 학술대회
2019 .10
-
Activation of Chemo/Immunotherapy in Tumor Microenvironment
한국생물공학회 학술대회
2018 .10
-
Biomedical Application of Polypeptide for Cancer Immunotherapy
한국생물공학회 학술대회
2022 .04
-
Towards Cancer Immunotherapy
한국생물공학회 학술대회
2017 .10
-
Enhancing Cancer Immunotherapy Using Biomaterials
한국고분자학회 학술대회 연구논문 초록집
2018 .10
-
Administration of functional DNA nanoparticle for cancer immunotherapy
한국고분자학회 학술대회 연구논문 초록집
2019 .04
-
Microfarbicated Platforms for Cancer Immunotherapy
한국생물공학회 학술대회
2020 .06
-
Cancer Immunotherapy & IL-7 : the past, present & future
한국생물공학회 학술대회
2019 .10
-
Development of Engineered Antibodies for Effective Diagnostics and Immunotherapy
한국생물공학회 학술대회
2019 .04
-
Combination of Metal-Phenolic Network with Electrical Ablation for Effective Cancer Immunotherapy
한국생물공학회 학술대회
2022 .09
-
Detection of Ara h1 protein using SWNTs nanobiosensor against peanut allergen
한국생물공학회 학술대회
2016 .04
-
Combination of Functional Nanoparticles with Electrical Ablation for Cancer Immunotherapy
한국생물공학회 학술대회
2020 .10
-
Update of early phase clinical trials in cancer immunotherapy
BMB Reports
2021 .01
-
NK Cell Encapsulation in Alginate-Chitosan-PEO Microspheres for Cancer Immunotherapy
한국생물공학회 학술대회
2022 .04
-
Nanostructured Dendritic Cells as a Platform for Enhanced Cancer Immunotherapy
한국고분자학회 학술대회 연구논문 초록집
2024 .09
이 논문의 저자 정보
최근 본 자료
댓글(0)
0
UCI(KEPA) : I410-151-24-02-090375843